一氧化氮供体阿霉素可累积进入耐阿霉素的人结肠癌细胞，诱导细胞毒性。
Nitric oxide donor doxorubicins accumulate into Doxorubicin-resistant human colon cancer cells inducing cytotoxicity.
作者信息
Chegaev Konstantin, Riganti Chiara, Lazzarato Loretta, Rolando Barbara, Guglielmo Stefano, Campia Ivana, Fruttero Roberta, Bosia Amalia, Gasco Alberto
机构信息
Department of Drug Science and Technology, University of Turin , Via Pietro Giuria 9, 10125 Torino, Italy.
Department of Genetics, Biology and Biochemistry, Turin School of Medicine, University of Turin , via Santena 5/bis, 10126 Torino, Italy.
出版信息
ACS Med Chem Lett. 2011 Apr 4;2(7):494-7. doi: 10.1021/ml100302t. eCollection 2011 Jul 14.
Abstract
Products 4 and 5, obtained by conjugation of doxorubicin with nitric oxide (NO) donor nitrooxy and phenylsulfonyl furoxan moieties, respectively, accumulate in doxorubicin-resistant human colon cancer cells (HT29-dx), inducing high cytotoxicity. This behavior parallels the ability of the compounds to generate NO, detected as nitrite, in these cells. Preliminary immunoblotting studies suggest that the mechanism that underlies the cytotoxic effect could involve inhibition of cellular drug efflux due to nitration of tyrosine residues of the MRP3 protein pump.
摘要
分别通过将阿霉素与一氧化氮（NO）供体硝氧基和苯磺酰基呋咱部分缀合得到的产物4和5，在耐阿霉素的人结肠癌细胞（HT29-dx）中积累，诱导高细胞毒性。这种行为与这些化合物在这些细胞中产生作为亚硝酸盐检测到的NO的能力相似。初步免疫印迹研究表明，细胞毒性作用背后的机制可能涉及由于MRP3蛋白泵酪氨酸残基的硝化而抑制细胞药物外排。
相似文献
1
Nitric oxide donor doxorubicins accumulate into Doxorubicin-resistant human colon cancer cells inducing cytotoxicity.一氧化氮供体阿霉素可累积进入耐阿霉素的人结肠癌细胞，诱导细胞毒性。
ACS Med Chem Lett. 2011 Apr 4;2(7):494-7. doi: 10.1021/ml100302t. eCollection 2011 Jul 14.
2
Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux.一氧化氮通过抑制药物外排逆转人结肠癌细胞对阿霉素的耐药性。
Cancer Res. 2005 Jan 15;65(2):516-25.
3
Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins.通过使用可释放一氧化氮的阿霉素靶向线粒体来克服多药耐药性。
Bioorg Med Chem. 2016 Mar 1;24(5):967-75. doi: 10.1016/j.bmc.2016.01.021. Epub 2016 Jan 14.
4
RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells.RhoA基因沉默可逆转人结肠癌细胞对阿霉素的耐药性。
Mol Cancer Res. 2008 Oct;6(10):1607-20. doi: 10.1158/1541-7786.MCR-08-0251.
5
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells.诱导型一氧化氮合酶的活性对于阿霉素在人结肠癌细胞中的细胞毒性和免疫原性效应是必需的。
Mol Cancer. 2009 Nov 19;8:108. doi: 10.1186/1476-4598-8-108.
6
Liposomal nitrooxy-doxorubicin: one step over caelyx in drug-resistant human cancer cells.脂质体硝基氧-阿霉素：在耐药性人类癌细胞中比凯素更具优势。
Mol Pharm. 2014 Sep 2;11(9):3068-79. doi: 10.1021/mp500257s. Epub 2014 Jul 30.
7
Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells.一氧化氮和 P-糖蛋白调节结肠癌细胞的吞噬作用。
J Cell Mol Med. 2011 Jul;15(7):1492-504. doi: 10.1111/j.1582-4934.2010.01137.x.
8
Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells.联苯双酯一氧化氮修饰衍生物对多药耐药癌细胞的抗癌疗效
J Cell Mol Med. 2016 Jun;20(6):1095-105. doi: 10.1111/jcmm.12796. Epub 2016 Feb 10.
9
Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells.辛伐他汀和RhoA沉默激活核因子-κB途径可增加阿霉素对人结肠癌HT29细胞的细胞毒性。
Mol Pharmacol. 2008 Aug;74(2):476-84. doi: 10.1124/mol.108.045286. Epub 2008 May 7.
10
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance.线粒体靶向硝基氧多柔比星：克服耐药性的新方法。
Mol Pharm. 2013 Jan 7;10(1):161-74. doi: 10.1021/mp300311b. Epub 2012 Dec 7.
引用本文的文献
1
Special Issue "Development and Synthesis of Biologically Active Compounds".特刊：生物活性化合物的开发与合成
Int J Mol Sci. 2024 Apr 4;25(7):4015. doi: 10.3390/ijms25074015.
2
Newly developed gas-assisted sonodynamic therapy in cancer treatment.癌症治疗中新开发的气体辅助声动力疗法。
Acta Pharm Sin B. 2023 Jul;13(7):2926-2954. doi: 10.1016/j.apsb.2022.12.021. Epub 2022 Dec 31.
3
Use of Enzymatically Activated Carbon Monoxide Donors for Sensitizing Drug-Resistant Tumor Cells.使用酶激活的一氧化碳供体来增敏耐药肿瘤细胞。
Int J Mol Sci. 2023 Jul 9;24(14):11258. doi: 10.3390/ijms241411258.
4
The Nitric Oxide Donor [Zn(PipNONO)Cl] Exhibits Antitumor Activity through Inhibition of Epithelial and Endothelial Mesenchymal Transitions.一氧化氮供体[Zn(PipNONO)Cl]通过抑制上皮和内皮间充质转化发挥抗肿瘤活性。
Cancers (Basel). 2022 Aug 31;14(17):4240. doi: 10.3390/cancers14174240.
5
Design, synthesis and biological evaluation of novel nitric oxide-donating podophyllotoxin derivatives as potential antiproliferative agents against multi-drug resistant leukemia cells.新型一氧化氮供体型鬼臼毒素衍生物作为潜在抗多药耐药白血病细胞增殖剂的设计、合成及生物学评价
RSC Adv. 2018 Oct 5;8(60):34266-34274. doi: 10.1039/c8ra06360e. eCollection 2018 Oct 4.
6
Doxorubicin-NO Releaser Molecular Hybrid Activatable by Green Light to Overcome Resistance in Breast Cancer Cells.可被绿光激活以克服乳腺癌细胞耐药性的阿霉素-NO释放分子杂化物
ACS Omega. 2022 Feb 24;7(9):7452-7459. doi: 10.1021/acsomega.1c03988. eCollection 2022 Mar 8.
7
Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms.通过纳米级药物递送平台探索克服P-糖蛋白介导的多药耐药性乳腺癌的新视野。
Curr Res Pharmacol Drug Discov. 2021 Sep 6;2:100054. doi: 10.1016/j.crphar.2021.100054. eCollection 2021.
8
S-Nitrosylation in Tumor Microenvironment.肿瘤微环境中的 S-亚硝基化作用。
Int J Mol Sci. 2021 Apr 27;22(9):4600. doi: 10.3390/ijms22094600.
9
Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics.一氧化氮在癌症及抗癌治疗中的最新进展
Vaccines (Basel). 2021 Jan 27;9(2):94. doi: 10.3390/vaccines9020094.
10
Nitric Oxide (NO) and NO Synthases (NOS)-Based Targeted Therapy for Colon Cancer.基于一氧化氮（NO）和一氧化氮合酶（NOS）的结肠癌靶向治疗
Cancers (Basel). 2020 Jul 13;12(7):1881. doi: 10.3390/cancers12071881.
本文引用的文献
1
Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein.苯磺酰基呋喃类化合物作为多药耐药相关蛋白 1 和 P 糖蛋白的调节剂。
J Med Chem. 2010 Aug 12;53(15):5467-75. doi: 10.1021/jm100066y.
2
Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials.P-糖蛋白调节剂在肿瘤学和神经退行性疾病中的前景：药学、生物学及诊断潜力
J Med Chem. 2010 Mar 11;53(5):1883-97. doi: 10.1021/jm900743c.
3
Identification of compounds selectively killing multidrug-resistant cancer cells.选择性杀死多药耐药癌细胞的化合物的鉴定。
Cancer Res. 2009 Nov 1;69(21):8293-301. doi: 10.1158/0008-5472.CAN-09-2422. Epub 2009 Oct 20.
4
RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells.RhoA基因沉默可逆转人结肠癌细胞对阿霉素的耐药性。
Mol Cancer Res. 2008 Oct;6(10):1607-20. doi: 10.1158/1541-7786.MCR-08-0251.
5
The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles.硝酸甘油生物活化与硝酸盐耐受性之谜：新进展、观点与问题
Br J Pharmacol. 2008 Sep;155(2):170-84. doi: 10.1038/bjp.2008.263. Epub 2008 Jun 23.
6
Nitrite anion: the key intermediate in alkyl nitrates degradative mechanism.亚硝酸根阴离子：烷基硝酸盐降解机制中的关键中间体。
J Med Chem. 2008 Jun 12;51(11):3318-21. doi: 10.1021/jm701390c. Epub 2008 Apr 29.
7
New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance.有机硝酸盐生物活化、硝酸盐耐受性和交叉耐受性的新见解。
Clin Res Cardiol. 2008 Jan;97(1):12-20. doi: 10.1007/s00392-007-0588-7. Epub 2007 Oct 19.
8
Targeting multidrug resistance in cancer.针对癌症中的多药耐药性
Nat Rev Drug Discov. 2006 Mar;5(3):219-34. doi: 10.1038/nrd1984.
9
Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux.一氧化氮通过抑制药物外排逆转人结肠癌细胞对阿霉素的耐药性。
Cancer Res. 2005 Jan 15;65(2):516-25.
10
Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate.低浓度硝酸甘油可抑制缺氧诱导的前列腺癌细胞对阿霉素的耐药性。
J Urol. 2003 Sep;170(3):1003-7. doi: 10.1097/01.ju.0000081126.71235.e0.
Zotero 插件